Vaxcyte Inc [PCVX] stock prices are down -0.85% to $30.39 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The PCVX shares have lost -2.60% over the last week, with a monthly amount drifted -59.19%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Vaxcyte Inc [NASDAQ: PCVX] stock has seen the most recent analyst activity on December 20, 2024, when Goldman initiated its Buy rating and assigned the stock a price target of $135. Previously, Mizuho started tracking the stock with Buy rating on December 07, 2023, and set its price target to $69. On April 18, 2023, TD Cowen initiated with a Outperform rating. Needham reiterated its Buy rating and increased its price target to $58 on January 03, 2023. Guggenheim initiated its recommendation with a Buy and recommended $66 as its price target on December 15, 2022. BTIG Research started tracking with a Buy rating for this stock on November 17, 2022, and assigned it a price target of $69.
The stock price of Vaxcyte Inc [PCVX] has been fluctuating between $27.66 and $121.06 over the past year. Currently, Wall Street analysts expect the stock to reach $140.5 within the next 12 months. Vaxcyte Inc [NASDAQ: PCVX] shares were valued at $30.39 at the most recent close of the market. An investor can expect a potential return of 362.32% based on the average PCVX price forecast.
Analyzing the PCVX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.13, Equity is -0.17 and Total Capital is -0.17. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 29.81 points at the first support level, and at 29.23 for the second support level. However, for the 1st resistance point, the stock is sitting at 31.29, and for the 2nd resistance point, it is at 32.19.
Ratios To Look Out For
It’s worth pointing out that Vaxcyte Inc [NASDAQ:PCVX]’s Current Ratio is 12.75. As well, the Quick Ratio is 12.75, while the Cash Ratio is 2.77.
Transactions by insiders
Recent insider trading involved Eydelman Mikhail, SVP, GEN COUNSEL & CORP SEC, that happened on Mar 05 ’25 when 5000.0 shares were sold. Officer, Eydelman Mikhail completed a deal on Mar 05 ’25 to buy 5000.0 shares. Meanwhile, CHIEF OPERATING OFFICER Wassil Jim sold 8000.0 shares on Mar 03 ’25.
